UPDATE 1-Amgen ends partnership with AstraZeneca on inflammation drug
May 22, 2015 at 17:10 PM EDT
May 22 (Reuters) - Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop an inflammation drug after it observed suicidal thoughts in the subjects of a trial.
